Pfizer bags approval for Neupogen biosimilar

23rd July 2018 Uncategorised 0

Pfizer’s Neupogen biosimilar Nivestym has been approved by the US Food and Drug Administration and is expected to hit the market at a “significant discount” to its reference drug.

More: Pfizer bags approval for Neupogen biosimilar
Source: News